| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention claims bioactive agent in the form of compound of formula (I) , where n is 1 or 2, m is 0, q is 0, t is 0, R9 is hydrogen, A is phenyl substituted by 1 or 2 groups selected out of alkyl with 1 or 2 carbon atoms, X is -CH2CR12R13- group where each of R12 and R13 is hydrogen, Q is OR1, R1 is hydrogen or alkyl with 1 to 7 carbon atoms, and agent application in medicine manufacturing for treatment of state selected out of group including resistance syndrome and diabetes. ^ EFFECT: method of treatment for mammal subject with state selected out of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver, cachexia, adiposity, atherosclerosis, and arteriosclerosis, involving daily oral administration of 1 to 400 mg of bioactive agent, and pharmaceutical composition based on the bioactive agent. ^ 12 cl, 1 tbl, 2 ex |
